Navigation Links
Isis Reports Financial Results and Highlights for First Quarter 2013
Date:5/7/2013

nt revenue under collaborative agreements$41,921$21,818Licensing and royalty revenue1,4391,417Total revenue43,36023,235Expenses:Research and development38,31238,714General and administrative3,4232,976Total operating expenses41,73541,690Income (loss) from operations1,625(18,455)Other income (expense):Equity in net loss of Regulus Therapeutics Inc.-(976)Investment income376600Interest expense(4,795)(5,179)Gain on investments, net1,05817Loss before income tax expense$(1,736)$(23,993)Income tax benefit (expense)64(2)Net loss$(1,672)$(23,995)Basic and diluted net loss per share$(0.02)$(0.24)Shares used in computing basic and diluted net loss per share101,875100,157 Isis Pharmaceuticals, IncReconciliation of GAAP to Pro Forma Basis: Condensed Consolidated Operating Expenses, (Income) Loss From Operations, and Net Income (Loss)(In Thousands)Three months ended,

March 31,20132012(unaudited)As reported operating expenses according to GAAP$41,735$41,690Excluding compensation expense related to equity awards

(2,869)(2,267)Pro forma operating expenses$38,866$39,423As reported income (loss) from operations according to GAAP$1,625$(18,455)Excluding compensation expense related to equity awards

(2,869)(2,267)Pro forma income (loss) from operations$4,494$(16,188)As reported net loss according to GAAP$(1,672)$(23,995)Excluding compensation expense related to equity awards

(2,869)(2,267)Pro forma net income (loss)$1,197$(21,728) Reconciliation of GAAP to Pro Forma BasisAs illustrated in the Selected Financial Information in this press release, pro forma operating expenses, pro forma income (loss) from operations, and proforma net income (loss) were adjusted from GAAP to exclude compensation expense related to equity awards, which are non-cash.  Isis has regularly reported non-GAAP measures for operating results as pro forma results.  These measures are provided as supplementary information and are not a substitute for fin
'/>"/>

SOURCE Isis Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Perrigo Reports Record Revenue and Adjusted Earnings
2. Discovery Labs Reports First Quarter 2013 Financial Results
3. Endo Reports First Quarter Financial Results
4. Landauer, Inc. Reports Fiscal 2013 Second Quarter Results
5. Array BioPharma Reports Financial Results for the Third Quarter of Fiscal 2013
6. Soligenix Reports First Quarter 2013 Financial Results and Highlights Recent Accomplishments
7. IRIDEX Reports 2013 First Quarter Results
8. Masimo Reports First Quarter 2013 Financial Results
9. Neurocrine Biosciences Reports First Quarter 2013 Results
10. Arena Pharmaceuticals Provides Corporate Update and Reports First Quarter 2013 Financial Results
11. Mylan Reports a 19% Increase in First Quarter 2013 Adjusted Diluted EPS to $0.62
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... TORONTO , May 4, 2015 ... that it intends to dividend to its stockholders a ... a definitive licensing agreement to license its RapidMist™ buccal ... (OTCQB:SMFI). As announced on April 23, 2015, ... respect of the licensing of its RapidMist™ buccal drug ...
(Date:5/4/2015)... BOSTON , May 4, 2015 PAREXEL International ... be presenting at the UBS Healthcare Conference on Monday, May ... Senior Vice President and Chief Financial Officer will be making ... a.m. ET. A live webcast of the presentation ... at www.PAREXEL.com in the Upcoming Events portion of ...
(Date:5/4/2015)... 2015 RadiologyAuction will have their first auction starting ... demonstrations at the end of the auction on May ... and Fuji Cr,s, Agfa and Sony, printers and GE ... Various imaging equipment will be available at later auctions ... years of buying and selling imaging equipment, the brokers ...
Breaking Medicine Technology:Generex Announces Intention to Dividend a Portion of Anticipated SMFI Securities to Its Stockholders upon a Reverse Stock Split 2Generex Announces Intention to Dividend a Portion of Anticipated SMFI Securities to Its Stockholders upon a Reverse Stock Split 3Generex Announces Intention to Dividend a Portion of Anticipated SMFI Securities to Its Stockholders upon a Reverse Stock Split 4Generex Announces Intention to Dividend a Portion of Anticipated SMFI Securities to Its Stockholders upon a Reverse Stock Split 5PAREXEL International to Present at UBS Healthcare Conference 2RadiologyAuction Announces Event Starting On May 5th 2
... Sept. 14 BioMarin Pharmaceutical Inc. (Nasdaq: BMRN ... Business Development of BioMarin, will present a company update at ... on Tuesday, September 21, 2010 at 3:30 p.m. ET.   ... of the conference call via the investor section of the ...
... WORCESTER, Mass., Sept. 14 Generex Biotechnology Corporation (Nasdaq: ... in drug delivery for metabolic diseases through the inner ... entered into an exclusive Product Licensing & Distribution Agreement ... marketing, distribution and sale of Generex Oral-lyn™, the Company,s ...
Cached Medicine Technology:BioMarin to Present at the UBS Global Life Sciences Conference 2Generex Announces Distribution Agreement for Generex Oral-lyn™ in Chile 2Generex Announces Distribution Agreement for Generex Oral-lyn™ in Chile 3
(Date:5/4/2015)... CA (PRWEB) May 04, 2015 In May ... Smalley took his own life. In the wake of this ... the Silent, an organization that exposes the grim reality of ... also a platform for Kirk and Laura to share their ... their tragedy from happening to another family — a mission ...
(Date:5/4/2015)... 04, 2015 METTLER TOLEDO has ... of Data Integrity in a GXP Regulated Laboratory ... presenter. This webinar will be presented on May ... Data integrity is a critical component of pharmaceutical ... agencies. However, in recent years an increasing number ...
(Date:5/4/2015)... The U.S. healthcare worker shortage crisis is expected ... senior citizens (1) and 27 million Obamacare-insured Americans (2) ... Additionally, as older healthcare employees retire, there will be ... Census Bureau, the number of American workers 65 and ... those 25 to 54 will likely increase 2%. (3) ...
(Date:5/4/2015)... 04, 2015 Now in its seventh ... leaders who have made outstanding contributions to the company, ... both in acute and post-acute care settings. The five ... Provider of the Year, Advanced Practice Clinician of the ... of the Year. Recipients are selected by IPC’s senior ...
(Date:5/4/2015)... Ticket Down is a reputable source for authentic tickets ... While the World Cup is the most known soccer tournament ... International Champions Cup is one of the biggest tournaments held ... for soccer in the United States set when Manchester United ... of Michigan. This year, the defending champion Manchester United club ...
Breaking Medicine News(10 mins):Health News:WWE Legend "Rowdy" Roddy Piper Teams Up with Stand for the Silent for Timely Anti-Bullying Campaign 2Health News:WWE Legend "Rowdy" Roddy Piper Teams Up with Stand for the Silent for Timely Anti-Bullying Campaign 3Health News:METTLER TOLEDO Announces Live Webinar on the Importance of Data Integrity in a GXP Regulated Laboratory 2Health News:U.S. Healthcare Worker Shortage Escalating: Sterling Warns Medical Practitioners to Rapidly Reverse Low Employee Retention 2Health News:U.S. Healthcare Worker Shortage Escalating: Sterling Warns Medical Practitioners to Rapidly Reverse Low Employee Retention 3Health News:U.S. Healthcare Worker Shortage Escalating: Sterling Warns Medical Practitioners to Rapidly Reverse Low Employee Retention 4Health News:IPC Healthcare Announces Clinicians of the Year 2Health News:IPC Healthcare Announces Clinicians of the Year 3Health News:Cheap 2015 International Champions Cup (ICC) Tickets: Ticket Down Slashes Ticket Prices on International Champions Cup (ICC) Presale Tickets 2Health News:Cheap 2015 International Champions Cup (ICC) Tickets: Ticket Down Slashes Ticket Prices on International Champions Cup (ICC) Presale Tickets 3Health News:Cheap 2015 International Champions Cup (ICC) Tickets: Ticket Down Slashes Ticket Prices on International Champions Cup (ICC) Presale Tickets 4
... rates have improved in Eastern England following the ... a new study published today (14 December) in ... An International Journal of Obstetrics and Gynaecology . ... (DH) produced good-practice guidance on commissioning cancer services ...
... (HealthDay News) -- An older woman,s sleep/wake cycle and levels ... a new study suggests. It found that the risk ... precedes dementia) was higher in older women with weaker circadian ... later in the day, compared to those who have a ...
... partner to cancer and who are still single four to ... of developing mental illness than those who have managed to ... Swedish widowers carried out at the Sahlgrenska Academy. More ... It has been scientifically proven that relatives of the deceased ...
... The U.S. Department of Justice filed a proposed consent ... requirements for three major tobacco companies to make internal ... the companies violated the Racketeer Influenced and Corrupt Organizations ... Tobacco Documents Library (LTDL). The order, once approved ...
... -- People with a certain type of muscular dystrophy have ... general population, although the actual risk is relatively low, a ... by progressive weakness and muscular wasting that can affect many ... The condition can range from mild to severe. The ...
... ways to counteract or disrupt the invasive nature of ... of cancer researchers. Now, researchers at Moffitt Cancer Center ... regulates metastases in some cancers that may be vulnerable ... proliferation and tumor growth. Ongoing collaboration by researchers ...
Cached Medicine News:Health News:Improvements in survival of gynecological cancer in the Anglia region of England 2Health News:'Body Clock' Might Affect Women's Dementia Risk 2Health News:New relationship important for the mental health of widowers 2Health News:UCSF to receive tobacco papers, funding to improve public access to the documents 2Health News:Type of Muscular Dystrophy Linked to Raised Cancer Risk 2Health News:Moffitt Cancer Center researchers find potential target for treating metastatic cancer 2Health News:Moffitt Cancer Center researchers find potential target for treating metastatic cancer 3
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: